TCIRG1 is highly expressed in various malignancies, including prostate cancer, breast cancer, and hepatocellular carcinoma [31], and is involved in multiple pathways that promote tumor growth, invasion, and metastasis. Here, TCIRG1 is linked to prostate carcinoma.